IBDEI29U ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36264,1,3,0)
 ;;=3^Thoracic DDD w/o Radiculopathy
 ;;^UTILITY(U,$J,358.3,36264,1,4,0)
 ;;=4^M51.24
 ;;^UTILITY(U,$J,358.3,36264,2)
 ;;=^5012247
 ;;^UTILITY(U,$J,358.3,36265,0)
 ;;=M51.15^^139^1841^1
 ;;^UTILITY(U,$J,358.3,36265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36265,1,3,0)
 ;;=3^T-L DDD w/ Radiculopathy
 ;;^UTILITY(U,$J,358.3,36265,1,4,0)
 ;;=4^M51.15
 ;;^UTILITY(U,$J,358.3,36265,2)
 ;;=^5012244
 ;;^UTILITY(U,$J,358.3,36266,0)
 ;;=Z02.5^^139^1842^1
 ;;^UTILITY(U,$J,358.3,36266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36266,1,3,0)
 ;;=3^Exam for Sports Participation (Primary)
 ;;^UTILITY(U,$J,358.3,36266,1,4,0)
 ;;=4^Z02.5
 ;;^UTILITY(U,$J,358.3,36266,2)
 ;;=^5062638
 ;;^UTILITY(U,$J,358.3,36267,0)
 ;;=20600^^140^1843^5^^^^1
 ;;^UTILITY(U,$J,358.3,36267,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36267,1,2,0)
 ;;=2^Drain/Inject, Joint/Bursa
 ;;^UTILITY(U,$J,358.3,36267,1,3,0)
 ;;=3^20600
 ;;^UTILITY(U,$J,358.3,36268,0)
 ;;=20605^^140^1843^1^^^^1
 ;;^UTILITY(U,$J,358.3,36268,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36268,1,2,0)
 ;;=2^Asp/Inj Interm Jt(Ac/Wrist/Ankle
 ;;^UTILITY(U,$J,358.3,36268,1,3,0)
 ;;=3^20605
 ;;^UTILITY(U,$J,358.3,36269,0)
 ;;=20610^^140^1843^2^^^^1
 ;;^UTILITY(U,$J,358.3,36269,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36269,1,2,0)
 ;;=2^Asp/Inj Maj Jt (Should/Hip/Knee
 ;;^UTILITY(U,$J,358.3,36269,1,3,0)
 ;;=3^20610
 ;;^UTILITY(U,$J,358.3,36270,0)
 ;;=20550^^140^1843^6^^^^1
 ;;^UTILITY(U,$J,358.3,36270,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36270,1,2,0)
 ;;=2^Inject Tendon/Ligament/Cyst 
 ;;^UTILITY(U,$J,358.3,36270,1,3,0)
 ;;=3^20550
 ;;^UTILITY(U,$J,358.3,36271,0)
 ;;=J1100^^140^1843^4^^^^1
 ;;^UTILITY(U,$J,358.3,36271,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36271,1,2,0)
 ;;=2^Dexamethasone Sodium Phos 1 mg
 ;;^UTILITY(U,$J,358.3,36271,1,3,0)
 ;;=3^J1100
 ;;^UTILITY(U,$J,358.3,36272,0)
 ;;=J0800^^140^1843^3^^^^1
 ;;^UTILITY(U,$J,358.3,36272,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36272,1,2,0)
 ;;=2^Corticotropin Inj up to 40 units
 ;;^UTILITY(U,$J,358.3,36272,1,3,0)
 ;;=3^J0800
 ;;^UTILITY(U,$J,358.3,36273,0)
 ;;=J1040^^140^1843^7^^^^1
 ;;^UTILITY(U,$J,358.3,36273,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36273,1,2,0)
 ;;=2^Methylprednisolone 80 Mg Inj
 ;;^UTILITY(U,$J,358.3,36273,1,3,0)
 ;;=3^J1040
 ;;^UTILITY(U,$J,358.3,36274,0)
 ;;=20552^^140^1843^8^^^^1
 ;;^UTILITY(U,$J,358.3,36274,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36274,1,2,0)
 ;;=2^Trigger Point(s) Inj,1-2 Muscles
 ;;^UTILITY(U,$J,358.3,36274,1,3,0)
 ;;=3^20552
 ;;^UTILITY(U,$J,358.3,36275,0)
 ;;=20553^^140^1843^9^^^^1
 ;;^UTILITY(U,$J,358.3,36275,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36275,1,2,0)
 ;;=2^Trigger Point(s) Inj,=/> 3 Muscles
 ;;^UTILITY(U,$J,358.3,36275,1,3,0)
 ;;=3^20553
 ;;^UTILITY(U,$J,358.3,36276,0)
 ;;=J0588^^140^1843^10^^^^1
 ;;^UTILITY(U,$J,358.3,36276,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36276,1,2,0)
 ;;=2^Xeomin (Incobotulinumtoxin A) 1 Unit
 ;;^UTILITY(U,$J,358.3,36276,1,3,0)
 ;;=3^J0588
 ;;^UTILITY(U,$J,358.3,36277,0)
 ;;=97597^^140^1844^2^^^^1
 ;;^UTILITY(U,$J,358.3,36277,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36277,1,2,0)
 ;;=2^Active Wound Care/20 Cm Or <
 ;;^UTILITY(U,$J,358.3,36277,1,3,0)
 ;;=3^97597
 ;;^UTILITY(U,$J,358.3,36278,0)
 ;;=97598^^140^1844^1^^^^1
 ;;^UTILITY(U,$J,358.3,36278,1,0)
 ;;=^358.31IA^3^2
